Rxsight Inc (RXST) is a Healthcare · Medical Devices company listed on NASDAQ. Price $5.20 (-2.26%), Market cap $0.24B, 52-week low–high $5.52 ~ $16.62.
RxSight, Inc., a commercial-stage medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. The company's RxSight system includes RxSight Light Adjustable Lens (LAL), an intraocular lens made of photosensitive material that changes shape in response to specific patterns of ultraviolet, which can be adjusted to improve uncorrected visual acuity; and RxSight light delivery device, an office-based light treatment device that delivers UV light in a
Financial statements, price targets, institutional (13F) holdings and related news for Rxsight Inc are updated in real time on BlackAll Trade.
Rxsight Inc trades at $5.20 (-2.26%). Real-time quotes and charts are available on BlackAll Trade.
Rxsight Inc has a market cap of about $0.24B.
RxSight, Inc., a commercial-stage medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in th